Sphingosine-1-phosphate: A Janus-faced mediator of fibrotic diseases
Authors:
- Josef PfeilschifterJPJosef Pfeilschifter
- Andrea HuwilerAHAndrea Huwiler
- 1 January 2013
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1831 (1) , 239-250
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Sphingosine-1-phosphate signaling and its role in diseaseTrends in Cell Biology, 2012
- Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytesKidney International, 2011
- Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidasesKidney International, 2011
- Sphingosine-1-phosphate and immune regulation: trafficking and beyondTrends in Pharmacological Sciences, 2011
- Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2Nature, 2010
- Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammationBiochimie, 2010
- Transforming growth factor-β2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-β2 by impeding CTGF expressionKidney International, 2009
- The vascular S1P gradient—Cellular sources and biological significanceBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptorCellular Signalling, 2007